BILITECH

Cell Therapy Solutions for Biliary Disease &

Disorders

Introduction

  • A cellular therapy platform for using primary cells to repair and replace diseased tissues and organs.
  • Advancing the huge potential of organoid technology in regenerative medicine.
  • A University of Cambridge spin out.
  • Beach head therapeutic market: Cholanglopathy

Flagship product: BiliDuct

  • Self regenerating bioengineered organ structure
  • To surgically replace damaged or diseased large bile ducts
  • Proof of Concept in large animals

Pipeline product: BiliCell

  • Injectable cellular therapy derived from primary cells to repair a diseased organ
  • To repair diseased bile ducts inside the liver
  • Proof-of-principle: small animals and human organs

Personnel & Credentials Section

Kourosh Saeb-Parsy

Kourosh Saeb-Parsy

CEO

Credential information
Kym Denny

Kym Denny

CEO

Credential information
Name Goes Here

Name Goes Here

Position

Credential information
Name Goes Here

Name Goes Here

Position

Credential information

Contact Us